4-Methyl-5-Thiazole Aldehyde

In the manufacture of cefodizime sodium, a third-generation injectable cephalosporin antibiotic listed under WHO Model List sections 6.2.1, the C-3 thiol‑tethered methylthiazole side chain originates directly from 4‑Methyl‑5‑Thiazole Aldehyde. The aldehyde is first reduced to 4‑methyl‑5‑thiazolemethanol. Reduction is performed with sodium borohydride (NaBH₄) in anhydrous methanol under a nitrogen blanket in a 5,000 L glass‑lined reactor (Pfaudler AE‑type) fitted with a half‑pipe jacket cooling circuit and an emergency rupture disc rated for 0.5 MPa. The molar feed ratio of NaBH₄ to aldehyde is maintained at 0.55–0.60:1.0 to balance full conversion against excessive hydrogen off‑gas. The semi‑batch addition of NaBH₄ solution is staged over 90 minutes while the jacket outlet coolant temperature is held at -15 °C, limiting the internal process temperature to -5 to 0 °C. Reaction calorimetry (Mettler Toledo RC1e) records an adiabatic temperature rise ΔT_ad of 28 °C; exceeding the target window promotes aldol condensation by‑products that are difficult to purge. After quench with pre‑cooled aqueous ammonium chloride, the methanol‑water phase is separated and the alcohol is extracted into dichloromethane. The organic layer is dried over molecular sieves to a water content below 500 ppm (ASTM E203). The alcohol is then converted to 4‑chloromethyl‑5‑methylthiazole hydrochloride with thionyl chloride (1.3 eq) in dichloromethane at 20–25 °C, off‑gas scrubbed through a 10 % w/w NaOH packed column. The resulting thiazole‑HCl salt is condensed with thioglycolic acid in demineralised water at pH 9.5–10.0 (adjusted with 50 % NaOH) to afford 5‑[(carboxymethyl)thio]‑4‑methylthiazole. Purity of the side‑chain intermediate is monitored by HPLC (USP 〈621〉; C18 column, phosphate buffer pH 3.0/acetonitrile gradient, UV detection at 254 nm) and must reach ≥99.0 area% with any single impurity limited to <0.3 area%. Residual 4‑Methyl‑5‑Thiazole Aldehyde in the alcohol intermediate is quantified by GC‑FID (ASTM D7756) and kept below 0.15 area% because carry‑over aldehyde reacts with the chlorinating agent, generating a hard‑to‑remove dimeric ether. The entire sequence is conducted under ICH Q7 GMP guidelines and is typically covered by a Type II Drug Master File filed with the US FDA. A critical incompatibility: contact with amine‑containing buffers during work‑up must be avoided, as traces of secondary amines catalyse aldehyde self‑condensation even at 4–8 °C.

What catalytic hydrogenation conditions minimise over‑reduction to 4‑methylthiazole?

When 4‑Methyl‑5‑Thiazole Aldehyde serves as the precursor for the flavour ingredients 4‑methyl‑5‑thiazoleethanol (FEMA 3204) and its acetate (FEMA 3205), catalytic hydrogenation is preferred over stoichiometric hydride for cost and waste reasons, yet the thiazole heterocycle is highly vulnerable to hydrogenolytic ring scission. Over‑reduction generates 4‑methylthiazole, an off‑flavour compound with an objectionable pyridine‑like note detectable at levels as low as 2 ppb in the final ester. A 5 % Pd/Al₂O₃ egg‑shell catalyst is charged into a 2,000 L Hastelloy stirred‑tank hydrogenator equipped with a hollow‑shaft gas‑induction impeller (Ekato Paravisc). The reactor is pressurised with hydrogen to 0.3–0.5 MPa and held at 30–40 °C. The gas‑liquid mass transfer coefficient k_La is maintained above 0.12 s⁻¹ via impeller tip speed of 3.5 m/s to avoid local aldehyde starvation at the catalyst surface, which otherwise promotes hydrogenolysis. Catalyst loading is 1.0–2.0 wt% relative to aldehyde; higher loadings increase the rate of ring‑opening. After hydrogen uptake ceases (typically 2.5–3.0 h), the slurry is filtered through a sparkler filter pre‑coated with diatomaceous earth (CELITE 535) and the filtrate is vacuum‑distilled using a wiped‑film evaporator (Pfaudler WFE‑type) at 105–108 °C and 1.3 kPa. Olfactory purity of the distillate is verified by GC‑Olfactometry with a panel and a minimum purity of 98.0 area% by GC‑FID is required to comply with EU Regulation (EC) No 1334/2008 for flavouring substances. The alcohol is subsequently acetylated with acetic anhydride at 60 °C without catalyst to form the acetate ester. A comparison of hydrogenation protocols is given in Table 1. An operational limitation: the aldehyde feedstock must be stored under nitrogen at ≤20 °C to inhibit autoxidation to the corresponding acid, which undergoes decarboxylation during distillation, producing 4‑methylthiazole as well. Raney‑nickel formulations, although active at lower pressure, are not used in scale‑up because pyrophoric catalyst handling requires specialised enclosed filtration and the selectivity to over‑reduction products reaches 3–8 % in pilot‑plant trials.

Data collated from pilot‑plant batch records at 2 m³ scale and open‑literature hydrogenation studies; Raney‑Ni over‑reduction rates represent worst‑case cycle times.

When 4‑Methyl‑5‑Thiazole Aldehyde is oxidised to 4‑methyl‑5‑thiazolecarboxylic acid for agrochemical actives

4‑Methyl‑5‑thiazolecarboxylic acid serves as the central aryl building block for a family of amide fungicides structurally related to the succinate dehydrogenase inhibitor (SDHI) class. The oxidation of the aldehyde is conducted in a 4,000 L glass‑lined reactor operated in biphasic mode: dichloromethane serves as the organic phase, and an aqueous phase contains 7.0 wt% active chlorine as sodium hypochlorite (NaOCl) along with 0.5 mol% TEMPO (2,2,6,6‑tetramethylpiperidine N‑oxyl) and 5 mol% KBr as co‑catalysts. The reaction is run at 0–5 °C with a jacket brine set to -10 °C; the heat of reaction measured by in‑situ reaction calorimetry requires precise dosing of NaOCl over 3–4 h to keep the internal temperature rise ΔT below 5 °C. Conversion is tracked by in‑line FT‑IR monitoring the disappearance of the aldehyde carbonyl stretch at 1680 cm⁻¹; the endpoint is reached when peak area falls below 1 % of baseline. Excess hypochlorite is quenched with sodium bisulfite and the aqueous phase is acidified to pH 2.0 with 37 % HCl, precipitating the carboxylic acid. The solid is centrifuged in a perforated‑basket centrifuge (Krauss‑Maffei HZ‑type), washed with deionised water, and dried in a conical vacuum dryer at 50 °C and 10 mbar until moisture is <0.5 % (ASTM D1364). The crude acid is then charged to a chlorination vessel where thionyl chloride (1.2 eq) in toluene at reflux converts it to the acid chloride. Off‑gases are passed through a 10 % NaOH caustic scrubber; residual SO₂ in the vent stack is continuously monitored and kept below 5 ppm per local emission permits. The acid chloride is immediately reacted with a substituted aniline in the presence of triethylamine to form the amide fungicide. Purity of the final active is determined by HPLC according to CIPAC MT 18.2.1, with a specification of ≥96.0 %. All substances are manufactured under REACH (EC No 1907/2006) and the active must undergo Annex II registration before commercialisation. A processing hazard: the intermediate sodium hypochlorite stream must be analysed for free NaOH content (0.2–0.5 %) because excess alkali hydrolyses the product acid and reduces yield. Published multi‑ton data for this specific TEMPO‑mediated oxidation are limited; the process described corresponds to pilot campaigns at 200–500 kg scale validated by heat‑flow DSC (ASTM E537) confirming thermal stability of the reaction mass up to 90 °C.

In the preparation of bidentate N,O‑Schiff base ligands employed for palladium‑catalysed Suzuki–Miyaura cross‑couplings at low metal loadings, 4‑Methyl‑5‑Thiazole Aldehyde is condensed with 2‑aminophenol in anhydrous ethanol under a nitrogen sweep. The reactor is a 500 L glass‑lined vessel fitted with a Dean–Stark trap; azeotropic distillation at 78–80 °C removes water and shifts the equilibrium to the imine. A precise molar ratio of aldehyde to amine of 1.02:1.0 is maintained to ensure complete consumption of the primary amine, since residual amine poisons the palladium centre during subsequent complexation. The reaction is monitored by reverse‑phase HPLC (acetonitrile/water gradient, UV at 275 nm); the reaction is judged complete when the imine peak reaches ≥95 area%. Upon cooling, the crystalline ligand is isolated by centrifugation, recrystallised from ethanol/water (7:3 v/v), and dried at 50 °C and 10 mbar for 8 h to achieve residual ethanol below 0.1 % (USP 〈467〉). Melting point determined by differential scanning calorimetry (ASTM D3418) falls in the range 102–104 °C. For formation of the palladium complex, the ligand is dissolved in dichloromethane and added to palladium(II) acetate in a 2:1 ligand‑to‑metal ratio. The resulting tetra‑coordinated Pd(II) complex exhibits a turnover number exceeding 10⁴ in the sterically hindered biaryl coupling of 2,6‑dimethylphenylboronic acid with 2‑bromotoluene, evaluated by GC conversion at 0.02 mol% Pd loading in toluene/K₃PO₄ at 100 °C. A critical raw‑material quality requirement: 4‑Methyl‑5‑Thiazole Aldehyde must be freshly short‑path distilled (jacket temperature 80 °C, pressure 2 mbar) before use; oligomeric impurities formed during storage react with the amine and produce dark‑coloured slurry that is impossible to remove by recrystallisation. The ligand product meets the general specification for cGMP pharmaceutical intermediate synthesis, with individual unspecified impurities below 0.10 %. No single industry standard governs the complex purity; contract manufacturers typically align with the residual solvent limits of ICH Q3C and provide high‑resolution mass and ¹H NMR lot‑specific certificates.

A critical synthon for contract research and heterocyclic compound libraries

Contract development and manufacturing organisations (CDMO) routinely employ 4‑Methyl‑5‑Thiazole Aldehyde as an electrophilic anchor in parallel synthesis of new chemical entities. Wittig olefination with (carbethoxymethylene)triphenylphosphorane in anhydrous THF at reflux for 18 h yields the α,β‑unsaturated ester with an E/Z ratio above 20:1 (determined by ¹H NMR coupling constants). Thiosemicarbazone formation with thiosemicarbazide in methanol at 60 °C generates intermediates screened against Mycobacterium tuberculosis H37Rv. Vilsmeier–Haack formylation (POCl₃/DMF) attacks the 4‑methyl substituent at 10–15 °C and installs a second aldehyde group, enabling branch extension. A standard catalogue grade is supplied with a certificate of analysis reporting purity >98 area% by GC (ASTM D4626) and water content <0.5 % by Karl Fischer titration (ASTM E203). Packaging in 1 kg and 25 kg UN‑rated fibre drums with antistatic polyethylene liner prevents moisture ingress. The material is classified under WGK 2 (German Water Hazard Class) and must be accompanied by a safety data sheet compliant with Regulation (EC) No 1907/2006, Annex II. A problematic storage condition: exposure to primary or secondary amines must be stringently avoided, because even vapour‑phase ammonia in a shared warehouse induces Schiff‑base formation that yields fluorescent yellow degradation products difficult to purge by crystallisation. The compliance landscape across the principal downstream segments is summarised in Table 2. Industrial‑scale continuous‑flow conditions for some of these library reactions remain proprietary, but the aldehyde’s kinetic profile in batch is well‑characterised in peer‑reviewed organic process journals.

In acidic copper electroplating formulations for decorative and printed‑circuit‑board through‑hole plating, a class of non‑ionic brighteners is prepared by reacting 4‑Methyl‑5‑Thiazole Aldehyde with epichlorohydrin and subsequently grafting onto polyetheramine backbones. The aldehyde is first converted to a quaternary oxirane intermediate by treatment with epichlorohydrin (2.5 eq) and powdered NaOH (1.05 eq) at 40–50 °C in a 1,000 L glass‑lined reactor with anchor agitator. The excess epichlorohydrin functions as both reactant and solvent. After 6 h, the slurry is filtered to remove NaCl, and the filtrate is stripped on a thin‑film evaporator (Buss‑SMS Filmtruder) at 90 °C and 2 mbar to reduce residual epichlorohydrin below 10 ppm (headspace GC, EPA Method 524.2). The purified oxirane is then coupled with Jeffamine® ED‑900 polyetheramine in water at 80 °C under nitrogen. The resulting brightener is dosed into a standard acid‑copper bath (CuSO₄·5H₂O 200 g/L, H₂SO₄ 50 g/L, Cl⁻ 50 ppm) at a concentration of 20–100 mg/L. Hull cell tests performed according to ASTM B604 show a shift in copper crystallite size from 1.2 µm to 0.2–0.5 µm as determined by SEM image analysis and XRD line broadening. The grain refinement produces a mirror‑bright deposit with thickness uniformity within ±5 % over a current‑density range of 1–6 A/dm². Stringent impurity limits apply to the aldehyde: total halide content (measured by ion chromatography per EPA Method 300.1) must not exceed 50 ppm, because any chloride variation pre‑adjusts the bath equilibrium and shifts the brightening window. The process operates under nitrogen blanketing to prevent aldehyde oxidation; all wetted parts in the oxirane loop are constructed from PTFE‑lined carbon steel to resist hydrochloric acid attack. Patents such as US 4,537,651 describe analogous thiazole‑based brighteners, but the precise structure‑property correlations for 4‑methyl‑substituted variants remain proprietary to plating chemical formulators.